|
Medtronic received a report that the axium detachment marker/pushwire had broken off in the echelon 10 microcatheter.The patient was undergoing surgery for treatment of a neurovascular abnormalities.It was noted the patient's vessel tortuosity was normal.It was reported that during the introduction of the thirteenth coil, the doctor noticed the detachment marker from the previous coil was visible in the internal carotid artery: the pushwire had broken off in the distal segment.There was no friction or difficulty noted during delivery, and everything felt normal.The marker/pushwire was retrieved by removing the coiling catheter.The distal portion of the device would be returned for analysis, but the proximal segment was discarded.There was no patient harm, and the procedure continued as normal.Ancillary devices include a benchmark 6f and echelon 10.
|
|
The axium prime pushwire was returned without the ancillary devices used in the procedure.Therefore, any contributing factors from these devices could not be assessed.The axium prime pushwire was decontaminated.The axium prime pushwire was returned without the introducer sheath.Only a portion of axium prime pushwire was returned for analysis.The actuator interface, positive load indicator and break indicator were not returned.The released wire was found extending out from the returned proximal end of the pushwire.The axium prime pushwire was noticed to be bent at two locations in the proximal area.The axium prime implant coil, the lumen stop, retainer ring and polypropylene were found to be missing and not returned.No anomalies were observed.Based on the device analysis and reported information, the report of ¿pusher kink/broke¿ was confirmed; however, the root cause could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|